{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:51:25Z","timestamp":1790373085277,"version":"4.1.0"},"reference-count":71,"publisher":"American Society of Hematology","issue":"25","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,11,28]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Ras pathway activation cooperates with Ink4a\/Arf locus deletion in B cells to induce a fully penetrant lymphoma\/leukemia phenotype in mice. These tumors resemble high-risk subtypes of human B-ALL, providing a convenient and highly reproducible model of refractory B-ALL.<\/jats:p>","DOI":"10.1182\/bloodadvances.2017012211","type":"journal-article","created":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T01:35:11Z","timestamp":1511314511000},"page":"2361-2374","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":14,"title":["Constitutive Ras signaling and Ink4a\/Arf inactivation cooperate during the development of B-ALL in mice"],"prefix":"10.1182","volume":"1","author":[{"given":"Tomasz","family":"Sewastianik","sequence":"first","affiliation":[{"name":"Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Department of Surgical Oncology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar","family":"Sukhdeo","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Biology and Regenerative Medicine, Cleveland Clinic, Cleveland, OH;"},{"name":"Department of Pathology, Case Western Reserve University, Cleveland, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay S.","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham & Women\u2019s Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Roberts","sequence":"additional","affiliation":[{"name":"Department of Pathology, St. Jude Children\u2019s Research Hospital, Memphis, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Alduaij","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"Dennis","sequence":"additional","affiliation":[{"name":"Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Lawney","sequence":"additional","affiliation":[{"name":"Center for Computational Cancer Biology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyuan","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessie","family":"Xiong","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina, Chapel Hill, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine E.","family":"Lemieux","sequence":"additional","affiliation":[{"name":"Bioinfo, Plantagenet, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine S.","family":"Pinkus","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham & Women\u2019s Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy N.","family":"Rich","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Biology and Regenerative Medicine, Cleveland Clinic, Cleveland, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Weinstock","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles G.","family":"Mullighan","sequence":"additional","affiliation":[{"name":"Department of Pathology, St. Jude Children\u2019s Research Hospital, Memphis, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman E.","family":"Sharpless","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina, Chapel Hill, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben D.","family":"Carrasco","sequence":"additional","affiliation":[{"name":"Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Department of Pathology, Brigham & Women\u2019s Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2017,11,21]]},"reference":[{"key":"2019111608024858600_B1","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"key":"2019111608024858600_B2","first-page":"129","article-title":"Where do we stand in the treatment of relapsed acute lymphoblastic leukemia?","volume-title":"Hematology Am Soc Hematol Educ Program","author":"Raetz","year":"2012"},{"key":"2019111608024858600_B3","first-page":"21","article-title":"Adolescents and young adults with acute lymphoblastic leukemia","volume-title":"Hematology Am Soc Hematol Educ Program","author":"Stock","year":"2010"},{"issue":"10","key":"2019111608024858600_B4","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1038\/leu.2010.177","article-title":"Genomic profiling of high-risk acute lymphoblastic leukemia","volume":"24","author":"Collins-Underwood","year":"2010","journal-title":"Leukemia"},{"issue":"6","key":"2019111608024858600_B5","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nrclinonc.2015.38","article-title":"Genomics in acute lymphoblastic leukaemia: insights and treatment implications","volume":"12","author":"Roberts","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"2019111608024858600_B6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1470-2045(08)70339-5","article-title":"A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study","volume":"10","author":"Den Boer","year":"2009","journal-title":"Lancet Oncol"},{"issue":"11","key":"2019111608024858600_B7","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/ng.469","article-title":"Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia","volume":"41","author":"Mullighan","year":"2009","journal-title":"Nat Genet"},{"issue":"23","key":"2019111608024858600_B8","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1073\/pnas.0811761106","article-title":"JAK mutations in high-risk childhood acute lymphoblastic leukemia","volume":"106","author":"Mullighan","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019111608024858600_B9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fonc.2014.00160","article-title":"Ras\/Raf\/MEK\/ERK pathway activation in childhood acute lymphoblastic leukemia and its therapeutic targeting","volume":"4","author":"Knight","year":"2014","journal-title":"Front Oncol"},{"issue":"5","key":"2019111608024858600_B10","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/bjh.13852","article-title":"Towards an understanding of the biology and targeted treatment of paediatric relapsed acute lymphoblastic leukaemia","volume":"172","author":"Irving","year":"2016","journal-title":"Br J Haematol"},{"issue":"7337","key":"2019111608024858600_B11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature09727","article-title":"CREBBP mutations in relapsed acute lymphoblastic leukaemia","volume":"471","author":"Mullighan","year":"2011","journal-title":"Nature"},{"issue":"23","key":"2019111608024858600_B12","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1182\/blood-2014-04-531871","article-title":"Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition","volume":"124","author":"Irving","year":"2014","journal-title":"Blood"},{"issue":"5","key":"2019111608024858600_B13","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/leu.2010.39","article-title":"Relapsed childhood high hyperdiploid acute lymphoblastic leukemia: presence of preleukemic ancestral clones and the secondary nature of microdeletions and RTK-RAS mutations","volume":"24","author":"Davidsson","year":"2010","journal-title":"Leukemia"},{"issue":"6","key":"2019111608024858600_B14","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1182\/blood.V82.6.1838.1838","article-title":"Role of p21 RAS in p210 bcr-abl transformation of murine myeloid cells","volume":"82","author":"Mandanas","year":"1993","journal-title":"Blood"},{"issue":"1","key":"2019111608024858600_B15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0092-8674(05)80094-7","article-title":"BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein","volume":"75","author":"Pendergast","year":"1993","journal-title":"Cell"},{"issue":"1","key":"2019111608024858600_B16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1073\/pnas.0911726107","article-title":"Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia","volume":"107","author":"Yoda","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"2019111608024858600_B17","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1128\/MCB.18.7.4109","article-title":"Gab1 acts as an adapter molecule linking the cytokine receptor gp130 to ERK mitogen-activated protein kinase","volume":"18","author":"Takahashi-Tezuka","year":"1998","journal-title":"Mol Cell Biol"},{"issue":"4","key":"2019111608024858600_B18","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1182\/blood-2011-12-389932","article-title":"Aberrant STAT5 and PI3K\/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia","volume":"120","author":"Tasian","year":"2012","journal-title":"Blood"},{"issue":"19","key":"2019111608024858600_B19","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1182\/blood-2011-04-345595","article-title":"Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies","volume":"118","author":"Hogan","year":"2011","journal-title":"Blood"},{"issue":"5906","key":"2019111608024858600_B20","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1126\/science.1164266","article-title":"Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia","volume":"322","author":"Mullighan","year":"2008","journal-title":"Science"},{"issue":"2","key":"2019111608024858600_B21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/leu.2012.155","article-title":"Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia","volume":"27","author":"Krentz","year":"2013","journal-title":"Leukemia"},{"issue":"6","key":"2019111608024858600_B22","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0092-8674(95)90214-7","article-title":"Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest","volume":"83","author":"Quelle","year":"1995","journal-title":"Cell"},{"issue":"10","key":"2019111608024858600_B23","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/35096061","article-title":"The INK4a\/ARF network in tumour suppression","volume":"2","author":"Sherr","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7191","key":"2019111608024858600_B24","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature06866","article-title":"BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros","volume":"453","author":"Mullighan","year":"2008","journal-title":"Nature"},{"issue":"11","key":"2019111608024858600_B25","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","article-title":"Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia","volume":"371","author":"Roberts","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"2019111608024858600_B26","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/nar\/25.6.1317","article-title":"B lymphocyte-specific, Cre-mediated mutagenesis in mice","volume":"25","author":"Rickert","year":"1997","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"2019111608024858600_B27","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1535-6108(04)00085-6","article-title":"Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects","volume":"5","author":"Tuveson","year":"2004","journal-title":"Cancer Cell"},{"issue":"1","key":"2019111608024858600_B28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0092-8674(00)81079-X","article-title":"Role of the INK4a locus in tumor suppression and cell mortality","volume":"85","author":"Serrano","year":"1996","journal-title":"Cell"},{"issue":"24","key":"2019111608024858600_B29","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1101\/gad.943001","article-title":"Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras","volume":"15","author":"Jackson","year":"2001","journal-title":"Genes Dev"},{"issue":"24","key":"2019111608024858600_B30","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1101\/gad.1158703","article-title":"Activated Kras and Ink4a\/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma","volume":"17","author":"Aguirre","year":"2003","journal-title":"Genes Dev"},{"issue":"5","key":"2019111608024858600_B31","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ccr.2006.03.028","article-title":"The PTEN and INK4A\/ARF tumor suppressors maintain myelolymphoid homeostasis and cooperate to constrain histiocytic sarcoma development in humans","volume":"9","author":"Carrasco","year":"2006","journal-title":"Cancer Cell"},{"issue":"7","key":"2019111608024858600_B32","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods"},{"issue":"7-8","key":"2019111608024858600_B33","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/mrd.22489","article-title":"The ImageJ ecosystem: an open platform for biomedical image analysis","volume":"82","author":"Schindelin","year":"2015","journal-title":"Mol Reprod Dev"},{"issue":"4","key":"2019111608024858600_B34","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/beheco\/ark016","article-title":"The unequal variance t-test is an underused alternative to Student\u2019s t-test and the Mann-Whitney U test","volume":"17","author":"Ruxton","year":"2006","journal-title":"Behav Ecol"},{"issue":"4","key":"2019111608024858600_B35","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ccr.2006.03.019","article-title":"High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients","volume":"9","author":"Carrasco","year":"2006","journal-title":"Cancer Cell"},{"issue":"3","key":"2019111608024858600_B36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nbt.2514","article-title":"Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples","volume":"31","author":"Cibulskis","year":"2013","journal-title":"Nat Biotechnol"},{"issue":"21","key":"2019111608024858600_B37","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1101\/gad.11.21.2822","article-title":"Cooperative effects of INK4a and ras in melanoma susceptibility in vivo","volume":"11","author":"Chin","year":"1997","journal-title":"Genes Dev"},{"issue":"4579","key":"2019111608024858600_B38","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1126\/science.7146913","article-title":"Mouse c-myc oncogene is located on chromosome 15 and translocated to chromosome 12 in plasmacytomas","volume":"218","author":"Crews","year":"1982","journal-title":"Science"},{"issue":"5","key":"2019111608024858600_B39","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ccr.2008.10.001","article-title":"H3K79 methylation profiles define murine and human MLL-AF4 leukemias","volume":"14","author":"Krivtsov","year":"2008","journal-title":"Cancer Cell"},{"issue":"2","key":"2019111608024858600_B40","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1535-6108(02)00032-6","article-title":"Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling","volume":"1","author":"Yeoh","year":"2002","journal-title":"Cancer Cell"},{"issue":"5","key":"2019111608024858600_B41","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1056\/NEJMoa0808253","article-title":"Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia","volume":"360","author":"Mullighan","year":"2009","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111608024858600_B42","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood.V70.4.948.948","article-title":"Clinical and biologic hallmarks of the Philadelphia chromosome in childhood acute lymphoblastic leukemia","volume":"70","author":"Ribeiro","year":"1987","journal-title":"Blood"},{"issue":"7","key":"2019111608024858600_B43","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/blood-2009-05-218560","article-title":"Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia","volume":"115","author":"Kang","year":"2010","journal-title":"Blood"},{"issue":"23","key":"2019111608024858600_B44","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1182\/blood-2009-08-239681","article-title":"Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome","volume":"116","author":"Harvey","year":"2010","journal-title":"Blood"},{"issue":"16","key":"2019111608024858600_B45","doi-asserted-by":"crossref","first-page":"6803","DOI":"10.1158\/0008-5472.CAN-08-0101","article-title":"Mutation of genes affecting the RAS pathway is common in childhood acute lymphoblastic leukemia","volume":"68","author":"Case","year":"2008","journal-title":"Cancer Res"},{"issue":"10","key":"2019111608024858600_B46","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1182\/blood-2016-02-696757","article-title":"The genetics of nodal marginal zone lymphoma","volume":"128","author":"Spina","year":"2016","journal-title":"Blood"},{"issue":"9","key":"2019111608024858600_B47","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1200710","article-title":"MYD88 L265P somatic mutation in Waldenstr\u00f6m\u2019s macroglobulinemia","volume":"367","author":"Treon","year":"2012","journal-title":"N Engl J Med"},{"issue":"26","key":"2019111608024858600_B48","doi-asserted-by":"crossref","first-page":"5991","DOI":"10.1182\/blood-2010-04-281527","article-title":"Endogenous oncogenic Nras mutation promotes aberrant GM-CSF signaling in granulocytic\/monocytic precursors in a murine model of chronic myelomonocytic leukemia","volume":"116","author":"Wang","year":"2010","journal-title":"Blood"},{"issue":"11","key":"2019111608024858600_B49","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1101\/gad.1673908","article-title":"Failure of CDKN2A\/B (INK4A\/B-ARF)-mediated tumor suppression and resistance to targeted therapy in acute lymphoblastic leukemia induced by BCR-ABL","volume":"22","author":"Mullighan","year":"2008","journal-title":"Genes Dev"},{"issue":"8","key":"2019111608024858600_B50","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1182\/blood.V85.8.2013.bloodjournal8582013","article-title":"Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia","volume":"85","author":"Sill","year":"1995","journal-title":"Blood"},{"issue":"14","key":"2019111608024858600_B51","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1182\/blood-2010-01-264093","article-title":"Immature B-cell progenitors survive oncogenic stress and efficiently initiate Ph+ B-acute lymphoblastic leukemia","volume":"116","author":"Signer","year":"2010","journal-title":"Blood"},{"issue":"17","key":"2019111608024858600_B52","doi-asserted-by":"crossref","first-page":"6688","DOI":"10.1073\/pnas.0602030103","article-title":"Arf gene loss enhances oncogenicity and limits imatinib response in mouse models of Bcr-Abl-induced acute lymphoblastic leukemia","volume":"103","author":"Williams","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"2019111608024858600_B53","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1182\/blood-2010-09-304402","article-title":"Expression of p16(INK4a) prevents cancer and promotes aging in lymphocytes","volume":"117","author":"Liu","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2019111608024858600_B54","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-012414-040424","article-title":"DNA replication stress as a hallmark of cancer","volume":"10","author":"Macheret","year":"2015","journal-title":"Annu Rev Pathol"},{"issue":"3","key":"2019111608024858600_B55","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.molonc.2014.11.001","article-title":"Myc and Ras oncogenes engage different energy metabolism programs and evoke distinct patterns of oxidative and DNA replication stress","volume":"9","author":"Maya-Mendoza","year":"2015","journal-title":"Mol Oncol"},{"issue":"1","key":"2019111608024858600_B56","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ccell.2015.05.008","article-title":"Erk negative feedback control enables Pre-B cell transformation and represents a therapeutic target in acute lymphoblastic leukemia","volume":"28","author":"Shojaee","year":"2015","journal-title":"Cancer Cell"},{"issue":"1-2","key":"2019111608024858600_B57","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10555-012-9405-5","article-title":"Animal models of leukemia: any closer to the real thing?","volume":"32","author":"Cook","year":"2013","journal-title":"Cancer Metastasis Rev"},{"key":"2019111608024858600_B58","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fonc.2014.00095","article-title":"Murine models of acute leukemia: important tools in current pediatric leukemia research","volume":"4","author":"Jacoby","year":"2014","journal-title":"Front Oncol"},{"issue":"1","key":"2019111608024858600_B59","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ccell.2015.06.005","article-title":"Activity of the type II JAK2 inhibitor CHZ868 in B cell acute lymphoblastic leukemia","volume":"28","author":"Wu","year":"2015","journal-title":"Cancer Cell"},{"issue":"3","key":"2019111608024858600_B60","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1182\/blood-2010-09-305383","article-title":"Loss of p19Arf in a Rag1(-\/-) B-cell precursor population initiates acute B-lymphoblastic leukemia","volume":"118","author":"Hauer","year":"2011","journal-title":"Blood"},{"issue":"10","key":"2019111608024858600_B61","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1182\/blood-2008-02-142190","article-title":"The biologic properties of leukemias arising from BCR\/ABL-mediated transformation vary as a function of developmental origin and activity of the p19ARF gene","volume":"112","author":"Wang","year":"2008","journal-title":"Blood"},{"issue":"5","key":"2019111608024858600_B62","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/leu.2011.15","article-title":"Activated K-Ras protein accelerates human MLL\/AF4-induced leukemo-lymphomogenicity in a transgenic mouse model","volume":"25","author":"Tamai","year":"2011","journal-title":"Leukemia"},{"issue":"3","key":"2019111608024858600_B63","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/leu.2009.286","article-title":"Genome-wide expression analysis of paired diagnosis-relapse samples in ALL indicates involvement of pathways related to DNA replication, cell cycle and DNA repair, independent of immune phenotype","volume":"24","author":"Staal","year":"2010","journal-title":"Leukemia"},{"issue":"2","key":"2019111608024858600_B64","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1182\/blood-2006-02-002824","article-title":"Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children\u2019s Oncology Group study","volume":"108","author":"Bhojwani","year":"2006","journal-title":"Blood"},{"issue":"26","key":"2019111608024858600_B65","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1182\/blood-2014-12-580068","article-title":"CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia","volume":"125","author":"Maude","year":"2015","journal-title":"Blood"},{"issue":"4","key":"2019111608024858600_B66","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/sj.leu.2403272","article-title":"RAS oncogene mutations and outcome of therapy for childhood acute lymphoblastic leukemia","volume":"18","author":"Perentesis","year":"2004","journal-title":"Leukemia"},{"issue":"2","key":"2019111608024858600_B67","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1182\/blood.V97.2.572","article-title":"Hemizygous p16(INK4A) deletion in pediatric acute lymphoblastic leukemia predicts independent risk of relapse","volume":"97","author":"Carter","year":"2001","journal-title":"Blood"},{"issue":"7","key":"2019111608024858600_B68","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1182\/blood.V93.7.2380","article-title":"Acquisition of p16(INK4A) and p15(INK4B) gene abnormalities between initial diagnosis and relapse in children with acute lymphoblastic leukemia","volume":"93","author":"Maloney","year":"1999","journal-title":"Blood"},{"issue":"2","key":"2019111608024858600_B69","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1365-2141.2001.02729.x","article-title":"INK4A\/ARF deletions are acquired at relapse in childhood acute lymphoblastic leukaemia: a paired study on 25 patients using real-time polymerase chain reaction","volume":"113","author":"Carter","year":"2001","journal-title":"Br J Haematol"},{"issue":"5","key":"2019111608024858600_B70","doi-asserted-by":"crossref","first-page":"e0155893","DOI":"10.1371\/journal.pone.0155893","article-title":"MEK inhibition sensitizes precursor B-cell acute lymphoblastic leukemia (B-ALL) cells to dexamethasone through modulation of mTOR activity and stimulation of autophagy","volume":"11","author":"Polak","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"2019111608024858600_B71","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.leukres.2008.10.006","article-title":"Converting cell lines representing hematological malignancies from glucocorticoid-resistant to glucocorticoid-sensitive: signaling pathway interactions","volume":"33","author":"Garza","year":"2009","journal-title":"Leuk Res"}],"updated-by":[{"DOI":"10.1182\/bloodadvances.2024014663","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000}}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/25\/2361\/879286\/advances012211.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/25\/2361\/879286\/advances012211.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T13:03:15Z","timestamp":1573909395000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/1\/25\/2361\/15758\/Constitutive-Ras-signaling-and-Ink4aArf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,21]]},"references-count":71,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2017,11,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2017012211","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,21]]}}}